About Opus Institutional Review Board
Opus Institutional Review Board is a Pharmaceuticals company, headquartered in Roswell, with 2 - 10 employees and annual revenue of $1M - $5M.
Opus IRB is focused on safeguarding the rights and welfare of human research participants. Highly experienced in all aspects of clinical research, Opus IRB is one of the few commercial Institutional Review Boards with only actively practicing physicians from all across the country. Our staff is c...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Opus Institutional Review Board Company Highlights
Phone Number
(678) 736-xxxx
Corporate Office Address
1175 Grimes Bridge Rd.
Roswell, 30075
Website
Opus Institutional Review Board Org
Opus Institutional Review Board has 1 Other employees.
Frequently Asked Questions About
Opus Institutional Review Board
Log in or sign up to get full contact details and additional support.
How do I contact Opus Institutional Review Board?
To contact Opus Institutional Review Board, visit opusirb.com.
What companies are similar to Opus Institutional Review Board?
Companies similar to Opus Institutional Review Board include PharmaLogic Holdings Corp., Agani Ltd., and Advarra Consulting.
Where is Opus Institutional Review Board headquartered?
Opus Institutional Review Board is headquartered at 1175 Grimes Bridge Rd., Roswell.
What is the main phone number for Opus Institutional Review Board?
The main phone number for Opus Institutional Review Board is (678) 736-xxxx.
What is the official website for Opus Institutional Review Board?
The official website for Opus Institutional Review Board is opusirb.com.
What is the annual revenue of Opus Institutional Review Board?
The annual revenue of Opus Institutional Review Board is $1M - $5M.
How many employees does Opus Institutional Review Board have?
Opus Institutional Review Board has 2 - 10 employees.
What industry is Opus Institutional Review Board in?
Opus Institutional Review Board is in the Pharmaceuticals industry.
Last updated: June 19, 2025